Article: Hoffman-La Roche to meet with FDA concerning Accutane.

HOFFMAN-LA ROCHE TO MEET WITH FDA CONCERNING ACCUTANE

WASHINGTON, April 26 /PRNewswire/ -- Hoffman-La Roche said today that it would move promptly to meet with the Food and Drug Administration (FDA) to implement several new innovative programs to re-emphasize long-standing warnings that Accutane (isotretinoin/ Roche) not be used by females who are pregnant or who intend to become pregnant while undergoing treatment.

In addition the company said it will pursue with the FDA other options to reinforce the appropriate use of Accutane, a drug prescribed for the treatment of severe recalcitrant cystic acne.

Roche announced its commitment to ...

Related newspaper, magazine, and journal articles:

 
 
Newsweek Harper's Magazine The Washington Post Chicago Tribune Crain's Chicago Business PRNewswire Pediatric News The Nation Advertising Age The Economist (US) A FREE trial gives you access to over 80 million articles! Access over 6,500 publications with a FREE trial!